Bristol Myers Squibb (BMYMP) Non-Current Deffered Revenue (2016 - 2019)
Bristol Myers Squibb (BMYMP) has disclosed Non-Current Deffered Revenue for 11 consecutive years, with $448.0 million as the latest value for Q1 2019.
- Quarterly Non-Current Deffered Revenue changed 0.22% to $448.0 million in Q1 2019 from the year-ago period, while the trailing twelve-month figure was $448.0 million through Mar 2019, changed 0.22% year-over-year, with the annual reading at $468.0 million for FY2018, 3.08% up from the prior year.
- Non-Current Deffered Revenue for Q1 2019 was $448.0 million at Bristol Myers Squibb, down from $468.0 million in the prior quarter.
- The five-year high for Non-Current Deffered Revenue was $697.0 million in Q1 2015, with the low at $447.0 million in Q1 2018.
- Average Non-Current Deffered Revenue over 5 years is $542.5 million, with a median of $528.0 million recorded in 2017.
- The sharpest move saw Non-Current Deffered Revenue crashed 35.99% in 2015, then grew 3.08% in 2018.
- Over 5 years, Non-Current Deffered Revenue stood at $586.0 million in 2015, then dropped by 6.66% to $547.0 million in 2016, then fell by 17.0% to $454.0 million in 2017, then increased by 3.08% to $468.0 million in 2018, then fell by 4.27% to $448.0 million in 2019.
- According to Business Quant data, Non-Current Deffered Revenue over the past three periods came in at $448.0 million, $468.0 million, and $486.0 million for Q1 2019, Q4 2018, and Q3 2018 respectively.